English

IDENIX PHARMACEUTICALS INC

EDGAR

IDIX Quarterly report (10-Q) · filed 2014-07-31

47 filing records in this dataset, filed from 2004-08-26 to 2014-07-31. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

-26.1 million USD

2014 Q2 · USD

Exact inputs and evidence

Revenue: -26071000 USD Source

Operating margin

248.35%

2014 Q2 · %

Exact inputs and evidence

Operating Income: -64748000 USD Source
Revenue: -26071000 USD Source

Operating cash flow

-32.2 million USD

2014 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -57082000 USD Source
Operating Cash Flow: -24877000 USD Source

Free cash flow

-32.5 million USD

2014 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -57082000 USD Source
Operating Cash Flow: -24877000 USD Source
Capital Expenditure: 336000 USD Source
Capital Expenditure: 11000 USD Source

Cash and cash equivalents: 178 million USD 2014-06-30 Source
Exact value

177613000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 151 million shares 2014-06-30 Source
Exact value

151470155 shares

Reported share-count change

13.07% · 17.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

133962861 shares · 2013-06-30· Source
151470155 shares · 2014-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

-29.6 million USD

2013-07-01 – 2014-06-30

Exact inputs and evidence

Revenue: 19000 USD · 2013-07-01 – 2013-09-30 Source
Revenue: -514000 USD · 2013-10-01 – 2013-12-31 Source
Revenue: -3007000 USD · 2014-01-01 – 2014-03-31 Source
Revenue: -26071000 USD · 2014-04-01 – 2014-06-30 Source

Net income

-161 million USD

2013-07-01 – 2014-06-30

Exact inputs and evidence

Net income: -33955000 USD · 2013-07-01 – 2013-09-30 Source
Net income: -28660000 USD · 2013-10-01 – 2013-12-31 Source
Net income: -34114000 USD · 2014-01-01 – 2014-03-31 Source
Net income: -64462000 USD · 2014-04-01 – 2014-06-30 Source

Operating cash flow

-113 million USD

2013-07-01 – 2014-06-30

Exact inputs and evidence

Operating cash flow: -81952000 USD · 2013-01-01 – 2013-09-30 Source
Operating cash flow: -52916000 USD · 2013-01-01 – 2013-06-30 Source
Operating cash flow: -109051000 USD · 2013-01-01 – 2013-12-31 Source
Operating cash flow: -81952000 USD · 2013-01-01 – 2013-09-30 Source
Operating cash flow: -24877000 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: -57082000 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: -24877000 USD · 2014-01-01 – 2014-03-31 Source

Capital expenditure

641 thousand USD

2013-07-01 – 2014-06-30

Exact inputs and evidence

Capital expenditure: 1074000 USD · 2013-01-01 – 2013-09-30 Source
Capital expenditure: 881000 USD · 2013-01-01 – 2013-06-30 Source
Capital expenditure: 1186000 USD · 2013-01-01 – 2013-12-31 Source
Capital expenditure: 1074000 USD · 2013-01-01 – 2013-09-30 Source
Capital expenditure: 11000 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 336000 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 11000 USD · 2014-01-01 – 2014-03-31 Source

Free cash flow

-114 million USD

2013-07-01 – 2014-06-30

Exact inputs and evidence

Operating cash flow: -81952000 USD · 2013-01-01 – 2013-09-30 Source
Operating cash flow: -52916000 USD · 2013-01-01 – 2013-06-30 Source
Operating cash flow: -109051000 USD · 2013-01-01 – 2013-12-31 Source
Operating cash flow: -81952000 USD · 2013-01-01 – 2013-09-30 Source
Operating cash flow: -24877000 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: -57082000 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: -24877000 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 1074000 USD · 2013-01-01 – 2013-09-30 Source
Capital expenditure: 881000 USD · 2013-01-01 – 2013-06-30 Source
Capital expenditure: 1186000 USD · 2013-01-01 – 2013-12-31 Source
Capital expenditure: 1074000 USD · 2013-01-01 – 2013-09-30 Source
Capital expenditure: 11000 USD · 2014-01-01 – 2014-03-31 Source
Capital expenditure: 336000 USD · 2014-01-01 – 2014-06-30 Source
Capital expenditure: 11000 USD · 2014-01-01 – 2014-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2014-07-31.

Financial data available through: 2013-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2013-12-31
Operating income: 11 of 11 periods available· newest 2013-12-31
Net income: 11 of 11 periods available· newest 2013-12-31
Operating cash flow: 11 of 11 periods available· newest 2013-12-31
Capital expenditure: 11 of 11 periods available· newest 2013-12-31
Total assets: 11 of 11 periods available· newest 2013-12-31
Total liabilities: 11 of 11 periods available· newest 2013-12-31
Current assets: 11 of 11 periods available· newest 2013-12-31
Current liabilities: 11 of 11 periods available· newest 2013-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2013-12-31
long term debt: No compatible figures in this window
Shares outstanding: 4 of 11 periods available· newest 2013-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-99.3%

Prior period

USD 69.66 million

2012-01-01 – 2012-12-31
Current period

USD 469,000

2013-01-01 – 2013-12-31

Exact inputs and evidence

469000 − 69663000 = -69194000 USD

69663000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
469000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · IDENIX PHARMACEUTICALS INC · 2013-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Year-over-year change in Revenue: -69194000 USD Concept: fundies:Revenue Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 469000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#591549 Filing: 000119312514073142 Input fundies:Revenue: 69663000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#672830 Filing: 000119312514073142
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 89.89 million

Prior period

−USD 32.4 million

2012-01-01 – 2012-12-31
Current period

−USD 122.29 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

-122287000 − -32400000 = -89887000 USD

-32400000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
-122287000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · IDENIX PHARMACEUTICALS INC · 2013-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Year-over-year change in Net income: -89887000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -122287000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#592698 Filing: 000119312514073142 Input fundies:NetIncome: -32400000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#674218 Filing: 000119312514073142
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 27.43 million

Prior period

−USD 81.62 million

2012-01-01 – 2012-12-31
Current period

−USD 109.05 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

-109051000 − -81622000 = -27429000 USD

-81622000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
-109051000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · IDENIX PHARMACEUTICALS INC · 2013-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Year-over-year change in Operating cash flow: -27429000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -109051000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#300173 Filing: 000119312514073142 Input fundies:OperatingCashFlow: -81622000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#669731 Filing: 000119312514073142
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+11.3%

Prior period

USD 1.07 million

2012-01-01 – 2012-12-31
Current period

USD 1.19 million

2013-01-01 – 2013-12-31

Exact inputs and evidence

1186000 − 1066000 = 120000 USD

1066000 USD · 2012-01-01 – 2012-12-31
Inspect prior input Prior source
1186000 USD · 2013-01-01 – 2013-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · IDENIX PHARMACEUTICALS INC · 2013-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Year-over-year change in Capital expenditure: 120000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1186000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#589524 Filing: 000119312514073142 Input fundies:CapitalExpenditure: 1066000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#670807 Filing: 000119312514073142
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2013 2013-01-01 – 2013-12-31

Revenue USD 469,000 100% of revenue
Operating costs Derived USD 124.19 million 26,480% of revenue
Operating income −USD 123.72 million −26,380% of revenue
Tax, interest and other Derived −USD 1.43 million −306% of revenue
Net income −USD 122.29 million −26,074% of revenue

Cash

Operating cash flow −USD 109.05 million −23,252% of revenue
Capital expenditure USD 1.19 million 253% of revenue
Free cash flow Derived −USD 110.24 million −23,505% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2004 Operating loss: operating costs were 109% of revenue.
2005 Operating loss: operating costs were 186% of revenue.
2006 Operating loss: operating costs were 227% of revenue.
2007 Operating loss: operating costs were 235% of revenue.
2008 Operating loss: operating costs were 827% of revenue.
2009 Operating loss: operating costs were 531% of revenue.
2010 Operating loss: operating costs were 714% of revenue.
2011 Operating loss: operating costs were 868% of revenue.
2012 Operating loss: operating costs were 151% of revenue.
2013 Operating loss: operating costs were 26,480% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2004 2004-01-01 – 2004-12-31	95389000	103582000 Derived	-8193000	-1949000 Derived	-6244000	-20313000 Derived	Source 2004-01-01 – 2004-12-31: 95389000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -8193000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -6244000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -16382000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 3931000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	64718000	120247000 Derived	-55529000	-4752000 Derived	-50777000	-62905000 Derived	Source 2005-01-01 – 2005-12-31: 64718000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -55529000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -50777000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -56319000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 6586000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	67377000	153096000 Derived	-85719000	-10632000 Derived	-75087000	-58394000 Derived	Source 2006-01-01 – 2006-12-31: 67377000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -85719000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -75087000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -48833000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 9561000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	68028000	159932000 Derived	-91904000	-9389000 Derived	-82515000	-77978000 Derived	Source 2007-01-01 – 2007-12-31: 68028000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -91904000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -82515000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -70679000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 7299000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	10049000	83059000 Derived	-73010000	-2804000 Derived	-70206000	-65004000 Derived	Source 2008-01-01 – 2008-12-31: 10049000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -73010000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -70206000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -62754000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 2250000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	12616000	67050000 Derived	-54434000	-1215000 Derived	-53219000	-36631000 Derived	Source 2009-01-01 – 2009-12-31: 12616000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -54434000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -53219000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -35960000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 671000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	10222000	72948000 Derived	-62726000	-1171000 Derived	-61555000	-28778000 Derived	Source 2010-01-01 – 2010-12-31: 10222000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -62726000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -61555000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -28051000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 727000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	6951000	60359000 Derived	-53408000	-1429000 Derived	-51979000	-55358000 Derived	Source 2011-01-01 – 2011-12-31: 6951000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -53408000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -51979000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -54521000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 837000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	69663000	105044000 Derived	-35381000	-2981000 Derived	-32400000	-82688000 Derived	Source 2012-01-01 – 2012-12-31: 69663000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -35381000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -32400000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -81622000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 1066000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	469000	124189000 Derived	-123720000	-1433000 Derived	-122287000	-110237000 Derived	Source 2013-01-01 – 2013-12-31: 469000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -123720000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -122287000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -109051000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 1186000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 469K 2013

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Revenue	95389000	Revenue: 95389000 Open source
20052005-12-31	Revenue	64718000	Revenue: 64718000 Open source
20062006-12-31	Revenue	67377000	Revenue: 67377000 Open source
20072007-12-31	Revenue	68028000	Revenue: 68028000 Open source
20082008-12-31	Revenue	10049000	Revenue: 10049000 Open source
20092009-12-31	Revenue	12616000	Revenue: 12616000 Open source
20102010-12-31	Revenue	10222000	Revenue: 10222000 Open source
20112011-12-31	Revenue	6951000	Revenue: 6951000 Open source
20122012-12-31	Revenue	69663000	Revenue: 69663000 Open source
20132013-12-31	Revenue	469000	Revenue: 469000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-99.3% 2013

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Year over year	222.6%	Revenue: 95389000 Open source Revenue: 29570000 Open source
20052005-12-31	Year over year	-32.2%	Revenue: 64718000 Open source Revenue: 95389000 Open source
20062006-12-31	Year over year	4.1%	Revenue: 67377000 Open source Revenue: 64718000 Open source
20072007-12-31	Year over year	1%	Revenue: 68028000 Open source Revenue: 67377000 Open source
20082008-12-31	Year over year	-85.2%	Revenue: 10049000 Open source Revenue: 68028000 Open source
20092009-12-31	Year over year	25.5%	Revenue: 12616000 Open source Revenue: 10049000 Open source
20102010-12-31	Year over year	-19%	Revenue: 10222000 Open source Revenue: 12616000 Open source
20112011-12-31	Year over year	-32%	Revenue: 6951000 Open source Revenue: 10222000 Open source
20122012-12-31	Year over year	902.2%	Revenue: 69663000 Open source Revenue: 6951000 Open source
20132013-12-31	Year over year	-99.3%	Revenue: 469000 Open source Revenue: 69663000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -26,379.5% 2013

Net margin -26,074% 2013

Free cash flow margin -23,504.7% 2013

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Operating margin	-8.6%	Operating Income: -8193000 Open source Revenue: 95389000 Open source
20052005-12-31	Operating margin	-85.8%	Operating Income: -55529000 Open source Revenue: 64718000 Open source
20062006-12-31	Operating margin	-127.2%	Operating Income: -85719000 Open source Revenue: 67377000 Open source
20072007-12-31	Operating margin	-135.1%	Operating Income: -91904000 Open source Revenue: 68028000 Open source
20082008-12-31	Operating margin	-726.5%	Operating Income: -73010000 Open source Revenue: 10049000 Open source
20092009-12-31	Operating margin	-431.5%	Operating Income: -54434000 Open source Revenue: 12616000 Open source
20102010-12-31	Operating margin	-613.6%	Operating Income: -62726000 Open source Revenue: 10222000 Open source
20112011-12-31	Operating margin	-768.3%	Operating Income: -53408000 Open source Revenue: 6951000 Open source
20122012-12-31	Operating margin	-50.8%	Operating Income: -35381000 Open source Revenue: 69663000 Open source
20132013-12-31	Operating margin	-26,379.5%	Operating Income: -123720000 Open source Revenue: 469000 Open source
20042004-12-31	Net margin	-6.5%	Net Income: -6244000 Open source Revenue: 95389000 Open source
20052005-12-31	Net margin	-78.5%	Net Income: -50777000 Open source Revenue: 64718000 Open source
20062006-12-31	Net margin	-111.4%	Net Income: -75087000 Open source Revenue: 67377000 Open source
20072007-12-31	Net margin	-121.3%	Net Income: -82515000 Open source Revenue: 68028000 Open source
20082008-12-31	Net margin	-698.6%	Net Income: -70206000 Open source Revenue: 10049000 Open source
20092009-12-31	Net margin	-421.8%	Net Income: -53219000 Open source Revenue: 12616000 Open source
20102010-12-31	Net margin	-602.2%	Net Income: -61555000 Open source Revenue: 10222000 Open source
20112011-12-31	Net margin	-747.8%	Net Income: -51979000 Open source Revenue: 6951000 Open source
20122012-12-31	Net margin	-46.5%	Net Income: -32400000 Open source Revenue: 69663000 Open source
20132013-12-31	Net margin	-26,074%	Net Income: -122287000 Open source Revenue: 469000 Open source
20042004-12-31	Free cash flow margin	-21.3%	Revenue: 95389000 Open source Operating Cash Flow: -16382000 Open source Capital Expenditure: 3931000 Open source
20052005-12-31	Free cash flow margin	-97.2%	Revenue: 64718000 Open source Operating Cash Flow: -56319000 Open source Capital Expenditure: 6586000 Open source
20062006-12-31	Free cash flow margin	-86.7%	Revenue: 67377000 Open source Operating Cash Flow: -48833000 Open source Capital Expenditure: 9561000 Open source
20072007-12-31	Free cash flow margin	-114.6%	Revenue: 68028000 Open source Operating Cash Flow: -70679000 Open source Capital Expenditure: 7299000 Open source
20082008-12-31	Free cash flow margin	-646.9%	Revenue: 10049000 Open source Operating Cash Flow: -62754000 Open source Capital Expenditure: 2250000 Open source
20092009-12-31	Free cash flow margin	-290.4%	Revenue: 12616000 Open source Operating Cash Flow: -35960000 Open source Capital Expenditure: 671000 Open source
20102010-12-31	Free cash flow margin	-281.5%	Revenue: 10222000 Open source Operating Cash Flow: -28051000 Open source Capital Expenditure: 727000 Open source
20112011-12-31	Free cash flow margin	-796.4%	Revenue: 6951000 Open source Operating Cash Flow: -54521000 Open source Capital Expenditure: 837000 Open source
20122012-12-31	Free cash flow margin	-118.7%	Revenue: 69663000 Open source Operating Cash Flow: -81622000 Open source Capital Expenditure: 1066000 Open source
20132013-12-31	Free cash flow margin	-23,504.7%	Revenue: 469000 Open source Operating Cash Flow: -109051000 Open source Capital Expenditure: 1186000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -109.1M 2013

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Operating cash flow	-16382000	Operating Cash Flow: -16382000 Open source
20052005-12-31	Operating cash flow	-56319000	Operating Cash Flow: -56319000 Open source
20062006-12-31	Operating cash flow	-48833000	Operating Cash Flow: -48833000 Open source
20072007-12-31	Operating cash flow	-70679000	Operating Cash Flow: -70679000 Open source
20082008-12-31	Operating cash flow	-62754000	Operating Cash Flow: -62754000 Open source
20092009-12-31	Operating cash flow	-35960000	Operating Cash Flow: -35960000 Open source
20102010-12-31	Operating cash flow	-28051000	Operating Cash Flow: -28051000 Open source
20112011-12-31	Operating cash flow	-54521000	Operating Cash Flow: -54521000 Open source
20122012-12-31	Operating cash flow	-81622000	Operating Cash Flow: -81622000 Open source
20132013-12-31	Operating cash flow	-109051000	Operating Cash Flow: -109051000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -110.2M 2013

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Free cash flow	-20313000	Operating Cash Flow: -16382000 Open source Capital Expenditure: 3931000 Open source
20052005-12-31	Free cash flow	-62905000	Operating Cash Flow: -56319000 Open source Capital Expenditure: 6586000 Open source
20062006-12-31	Free cash flow	-58394000	Operating Cash Flow: -48833000 Open source Capital Expenditure: 9561000 Open source
20072007-12-31	Free cash flow	-77978000	Operating Cash Flow: -70679000 Open source Capital Expenditure: 7299000 Open source
20082008-12-31	Free cash flow	-65004000	Operating Cash Flow: -62754000 Open source Capital Expenditure: 2250000 Open source
20092009-12-31	Free cash flow	-36631000	Operating Cash Flow: -35960000 Open source Capital Expenditure: 671000 Open source
20102010-12-31	Free cash flow	-28778000	Operating Cash Flow: -28051000 Open source Capital Expenditure: 727000 Open source
20112011-12-31	Free cash flow	-55358000	Operating Cash Flow: -54521000 Open source Capital Expenditure: 837000 Open source
20122012-12-31	Free cash flow	-82688000	Operating Cash Flow: -81622000 Open source Capital Expenditure: 1066000 Open source
20132013-12-31	Free cash flow	-110237000	Operating Cash Flow: -109051000 Open source Capital Expenditure: 1186000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

24.8% 2013

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Liabilities / assets	41.7%	Total Liabilities: 78060000 Open source Total Assets: 187118000 Open source
20052005-12-31	Liabilities / assets	25.5%	Total Liabilities: 70770000 Open source Total Assets: 277657000 Open source
20062006-12-31	Liabilities / assets	37.8%	Total Liabilities: 86440000 Open source Total Assets: 228465000 Open source
20072007-12-31	Liabilities / assets	57.1%	Total Liabilities: 91702000 Open source Total Assets: 160540000 Open source
20082008-12-31	Liabilities / assets	90.8%	Total Liabilities: 72427000 Open source Total Assets: 79780000 Open source
20092009-12-31	Liabilities / assets	107.1%	Total Liabilities: 82103000 Open source Total Assets: 76650000 Open source
20102010-12-31	Liabilities / assets	144.5%	Total Liabilities: 100980000 Open source Total Assets: 69884000 Open source
20112011-12-31	Liabilities / assets	63.7%	Total Liabilities: 89819000 Open source Total Assets: 141044000 Open source
20122012-12-31	Liabilities / assets	12.6%	Total Liabilities: 31705000 Open source Total Assets: 250865000 Open source
20132013-12-31	Liabilities / assets	24.8%	Total Liabilities: 35014000 Open source Total Assets: 141011000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

7.13× 2013

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Current assets / current liabilities	3.35×	Current Assets: 99986000 Open source Current Liabilities: 29863000 Open source
20052005-12-31	Current assets / current liabilities	6.14×	Current Assets: 199585000 Open source Current Liabilities: 32516000 Open source
20062006-12-31	Current assets / current liabilities	3.94×	Current Assets: 147605000 Open source Current Liabilities: 37446000 Open source
20072007-12-31	Current assets / current liabilities	3.37×	Current Assets: 103719000 Open source Current Liabilities: 30734000 Open source
20082008-12-31	Current assets / current liabilities	2.56×	Current Assets: 50041000 Open source Current Liabilities: 19576000 Open source
20092009-12-31	Current assets / current liabilities	2.81×	Current Assets: 51580000 Open source Current Liabilities: 18344000 Open source
20102010-12-31	Current assets / current liabilities	2.48×	Current Assets: 49490000 Open source Current Liabilities: 19994000 Open source
20112011-12-31	Current assets / current liabilities	2.45×	Current Assets: 123838000 Open source Current Liabilities: 50525000 Open source
20122012-12-31	Current assets / current liabilities	14.93×	Current Assets: 237792000 Open source Current Liabilities: 15932000 Open source
20132013-12-31	Current assets / current liabilities	7.13×	Current Assets: 129752000 Open source Current Liabilities: 18190000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2004 2004-01-01 – 2004-12-31	−USD 6.24 million Exact value Exact value: -6244000 USD 2004-01-01 – 2004-12-31: -6244000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDENIX PHARMACEUTICALS INC · 2004-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Net Income: -6244000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6244000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-07-001620.txt#26323 The citation records this snapshot. The page link may show a newer release later.	−USD 16.38 million Exact value Exact value: -16382000 USD 2004-01-01 – 2004-12-31: -16382000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDENIX PHARMACEUTICALS INC · 2004-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Operating Cash Flow: -16382000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16382000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-07-001620.txt#27293 The citation records this snapshot. The page link may show a newer release later.	USD 3.93 million Exact value Exact value: 3931000 USD 2004-01-01 – 2004-12-31: 3931000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDENIX PHARMACEUTICALS INC · 2004-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Capital Expenditure: 3931000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3931000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-07-001620.txt#27423 The citation records this snapshot. The page link may show a newer release later.	−USD 20.31 million Calculation and evidence -16382000 − 3931000 USD Exact free cash flow: -20313000 USD 2004-01-01 – 2004-12-31: -16382000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 3931000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDENIX PHARMACEUTICALS INC · 2004-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Free cash flow: -20313000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16382000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-07-001620.txt#27293 Input fundies:CapitalExpenditure: 3931000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-07-001620.txt#27423 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 50.78 million Exact value Exact value: -50777000 USD 2005-01-01 – 2005-12-31: -50777000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDENIX PHARMACEUTICALS INC · 2005-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Net Income: -50777000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -50777000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-08-001798.txt#27347 The citation records this snapshot. The page link may show a newer release later.	−USD 56.32 million Exact value Exact value: -56319000 USD 2005-01-01 – 2005-12-31: -56319000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDENIX PHARMACEUTICALS INC · 2005-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Operating Cash Flow: -56319000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -56319000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-08-001798.txt#28335 The citation records this snapshot. The page link may show a newer release later.	USD 6.59 million Exact value Exact value: 6586000 USD 2005-01-01 – 2005-12-31: 6586000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDENIX PHARMACEUTICALS INC · 2005-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Capital Expenditure: 6586000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6586000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-08-001798.txt#28462 The citation records this snapshot. The page link may show a newer release later.	−USD 62.91 million Calculation and evidence -56319000 − 6586000 USD Exact free cash flow: -62905000 USD 2005-01-01 – 2005-12-31: -56319000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 6586000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDENIX PHARMACEUTICALS INC · 2005-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Free cash flow: -62905000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -56319000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-08-001798.txt#28335 Input fundies:CapitalExpenditure: 6586000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-08-001798.txt#28462 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 75.09 million Exact value Exact value: -75087000 USD 2006-01-01 – 2006-12-31: -75087000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDENIX PHARMACEUTICALS INC · 2006-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Net Income: -75087000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -75087000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-09-001542.txt#25109 The citation records this snapshot. The page link may show a newer release later.	−USD 48.83 million Exact value Exact value: -48833000 USD 2006-01-01 – 2006-12-31: -48833000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDENIX PHARMACEUTICALS INC · 2006-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Operating Cash Flow: -48833000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48833000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-09-001542.txt#25883 The citation records this snapshot. The page link may show a newer release later.	USD 9.56 million Exact value Exact value: 9561000 USD 2006-01-01 – 2006-12-31: 9561000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDENIX PHARMACEUTICALS INC · 2006-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Capital Expenditure: 9561000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9561000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-09-001542.txt#26010 The citation records this snapshot. The page link may show a newer release later.	−USD 58.39 million Calculation and evidence -48833000 − 9561000 USD Exact free cash flow: -58394000 USD 2006-01-01 – 2006-12-31: -48833000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 9561000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDENIX PHARMACEUTICALS INC · 2006-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Free cash flow: -58394000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -48833000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-09-001542.txt#25883 Input fundies:CapitalExpenditure: 9561000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950135-09-001542.txt#26010 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 82.52 million Exact value Exact value: -82515000 USD 2007-01-01 – 2007-12-31: -82515000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDENIX PHARMACEUTICALS INC · 2007-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Net Income: -82515000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -82515000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0001144204-10-012301.txt#12346 The citation records this snapshot. The page link may show a newer release later.	−USD 70.68 million Exact value Exact value: -70679000 USD 2007-01-01 – 2007-12-31: -70679000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDENIX PHARMACEUTICALS INC · 2007-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Operating Cash Flow: -70679000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -70679000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0001144204-10-012301.txt#12886 The citation records this snapshot. The page link may show a newer release later.	USD 7.3 million Exact value Exact value: 7299000 USD 2007-01-01 – 2007-12-31: 7299000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDENIX PHARMACEUTICALS INC · 2007-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Capital Expenditure: 7299000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7299000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0001144204-10-012301.txt#12946 The citation records this snapshot. The page link may show a newer release later.	−USD 77.98 million Calculation and evidence -70679000 − 7299000 USD Exact free cash flow: -77978000 USD 2007-01-01 – 2007-12-31: -70679000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 7299000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDENIX PHARMACEUTICALS INC · 2007-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Free cash flow: -77978000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -70679000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0001144204-10-012301.txt#12886 Input fundies:CapitalExpenditure: 7299000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0001144204-10-012301.txt#12946 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 70.21 million Exact value Exact value: -70206000 USD 2008-01-01 – 2008-12-31: -70206000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDENIX PHARMACEUTICALS INC · 2008-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Net Income: -70206000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -70206000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950123-11-022637.txt#12018 The citation records this snapshot. The page link may show a newer release later.	−USD 62.75 million Exact value Exact value: -62754000 USD 2008-01-01 – 2008-12-31: -62754000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDENIX PHARMACEUTICALS INC · 2008-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Operating Cash Flow: -62754000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -62754000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950123-11-022637.txt#12270 The citation records this snapshot. The page link may show a newer release later.	USD 2.25 million Exact value Exact value: 2250000 USD 2008-01-01 – 2008-12-31: 2250000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDENIX PHARMACEUTICALS INC · 2008-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Capital Expenditure: 2250000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2250000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950123-11-022637.txt#12312 The citation records this snapshot. The page link may show a newer release later.	−USD 65 million Calculation and evidence -62754000 − 2250000 USD Exact free cash flow: -65004000 USD 2008-01-01 – 2008-12-31: -62754000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 2250000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDENIX PHARMACEUTICALS INC · 2008-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Free cash flow: -65004000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -62754000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950123-11-022637.txt#12270 Input fundies:CapitalExpenditure: 2250000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/0000950123-11-022637.txt#12312 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 53.22 million Exact value Exact value: -53219000 USD 2009-01-01 – 2009-12-31: -53219000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDENIX PHARMACEUTICALS INC · 2009-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Net Income: -53219000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -53219000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312512097966/idix-20111231.xml#33132 Filing: 000119312512097966 The citation records this snapshot. The page link may show a newer release later.	−USD 35.96 million Exact value Exact value: -35960000 USD 2009-01-01 – 2009-12-31: -35960000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDENIX PHARMACEUTICALS INC · 2009-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Operating Cash Flow: -35960000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35960000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312512097966/idix-20111231.xml#57367 Filing: 000119312512097966 The citation records this snapshot. The page link may show a newer release later.	USD 671,000 Exact value Exact value: 671000 USD 2009-01-01 – 2009-12-31: 671000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDENIX PHARMACEUTICALS INC · 2009-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Capital Expenditure: 671000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 671000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312512097966/idix-20111231.xml#57895 Filing: 000119312512097966 The citation records this snapshot. The page link may show a newer release later.	−USD 36.63 million Calculation and evidence -35960000 − 671000 USD Exact free cash flow: -36631000 USD 2009-01-01 – 2009-12-31: -35960000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 671000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDENIX PHARMACEUTICALS INC · 2009-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Free cash flow: -36631000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -35960000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312512097966/idix-20111231.xml#57367 Filing: 000119312512097966 Input fundies:CapitalExpenditure: 671000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312512097966/idix-20111231.xml#57895 Filing: 000119312512097966 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 61.56 million Exact value Exact value: -61555000 USD 2010-01-01 – 2010-12-31: -61555000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDENIX PHARMACEUTICALS INC · 2010-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Net Income: -61555000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -61555000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312513074136/idix-20121231.xml#89781 Filing: 000119312513074136 The citation records this snapshot. The page link may show a newer release later.	−USD 28.05 million Exact value Exact value: -28051000 USD 2010-01-01 – 2010-12-31: -28051000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDENIX PHARMACEUTICALS INC · 2010-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Operating Cash Flow: -28051000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -28051000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312513074136/idix-20121231.xml#81591 Filing: 000119312513074136 The citation records this snapshot. The page link may show a newer release later.	USD 727,000 Exact value Exact value: 727000 USD 2010-01-01 – 2010-12-31: 727000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDENIX PHARMACEUTICALS INC · 2010-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Capital Expenditure: 727000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 727000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312513074136/idix-20121231.xml#83132 Filing: 000119312513074136 The citation records this snapshot. The page link may show a newer release later.	−USD 28.78 million Calculation and evidence -28051000 − 727000 USD Exact free cash flow: -28778000 USD 2010-01-01 – 2010-12-31: -28051000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 727000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDENIX PHARMACEUTICALS INC · 2010-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Free cash flow: -28778000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -28051000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312513074136/idix-20121231.xml#81591 Filing: 000119312513074136 Input fundies:CapitalExpenditure: 727000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312513074136/idix-20121231.xml#83132 Filing: 000119312513074136 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 51.98 million Exact value Exact value: -51979000 USD 2011-01-01 – 2011-12-31: -51979000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDENIX PHARMACEUTICALS INC · 2011-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Net Income: -51979000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -51979000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#79460 Filing: 000119312514073142 The citation records this snapshot. The page link may show a newer release later.	−USD 54.52 million Exact value Exact value: -54521000 USD 2011-01-01 – 2011-12-31: -54521000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDENIX PHARMACEUTICALS INC · 2011-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Operating Cash Flow: -54521000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -54521000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#75221 Filing: 000119312514073142 The citation records this snapshot. The page link may show a newer release later.	USD 837,000 Exact value Exact value: 837000 USD 2011-01-01 – 2011-12-31: 837000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDENIX PHARMACEUTICALS INC · 2011-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Capital Expenditure: 837000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 837000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#76296 Filing: 000119312514073142 The citation records this snapshot. The page link may show a newer release later.	−USD 55.36 million Calculation and evidence -54521000 − 837000 USD Exact free cash flow: -55358000 USD 2011-01-01 – 2011-12-31: -54521000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 837000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDENIX PHARMACEUTICALS INC · 2011-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Free cash flow: -55358000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -54521000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#75221 Filing: 000119312514073142 Input fundies:CapitalExpenditure: 837000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#76296 Filing: 000119312514073142 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 32.4 million Exact value Exact value: -32400000 USD 2012-01-01 – 2012-12-31: -32400000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDENIX PHARMACEUTICALS INC · 2012-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Net Income: -32400000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32400000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#674218 Filing: 000119312514073142 The citation records this snapshot. The page link may show a newer release later.	−USD 81.62 million Exact value Exact value: -81622000 USD 2012-01-01 – 2012-12-31: -81622000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDENIX PHARMACEUTICALS INC · 2012-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Operating Cash Flow: -81622000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -81622000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#669731 Filing: 000119312514073142 The citation records this snapshot. The page link may show a newer release later.	USD 1.07 million Exact value Exact value: 1066000 USD 2012-01-01 – 2012-12-31: 1066000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDENIX PHARMACEUTICALS INC · 2012-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Capital Expenditure: 1066000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1066000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#670807 Filing: 000119312514073142 The citation records this snapshot. The page link may show a newer release later.	−USD 82.69 million Calculation and evidence -81622000 − 1066000 USD Exact free cash flow: -82688000 USD 2012-01-01 – 2012-12-31: -81622000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 1066000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDENIX PHARMACEUTICALS INC · 2012-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Free cash flow: -82688000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -81622000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#669731 Filing: 000119312514073142 Input fundies:CapitalExpenditure: 1066000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#670807 Filing: 000119312514073142 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 122.29 million Exact value Exact value: -122287000 USD 2013-01-01 – 2013-12-31: -122287000 USD Inspect Net Income Open source Share or cite Citation for Net Income · IDENIX PHARMACEUTICALS INC · 2013-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Net Income: -122287000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -122287000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#592698 Filing: 000119312514073142 The citation records this snapshot. The page link may show a newer release later.	−USD 109.05 million Exact value Exact value: -109051000 USD 2013-01-01 – 2013-12-31: -109051000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · IDENIX PHARMACEUTICALS INC · 2013-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Operating Cash Flow: -109051000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -109051000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#300173 Filing: 000119312514073142 The citation records this snapshot. The page link may show a newer release later.	USD 1.19 million Exact value Exact value: 1186000 USD 2013-01-01 – 2013-12-31: 1186000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · IDENIX PHARMACEUTICALS INC · 2013-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Capital Expenditure: 1186000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1186000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#589524 Filing: 000119312514073142 The citation records this snapshot. The page link may show a newer release later.	−USD 110.24 million Calculation and evidence -109051000 − 1186000 USD Exact free cash flow: -110237000 USD 2013-01-01 – 2013-12-31: -109051000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 1186000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · IDENIX PHARMACEUTICALS INC · 2013-12-31 IDENIX PHARMACEUTICALS INC (edgar:1093649) Free cash flow: -110237000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T02:27:09Z Snapshot: 80044120673fb798150a9eabb0e567eeee5ba09d3f5c7866784865711094c240 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1093649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -109051000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#300173 Filing: 000119312514073142 Input fundies:CapitalExpenditure: 1186000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/idix-20131231.xml#589524 Filing: 000119312514073142 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

47 filings · 1,087 latest values · 1,087 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001093649, 1093649, IDIX, edgar:1093649

Also known as IDENIX PHARMACEUTICALS INC, NOVIRIO PHARMACEUTICALS LTD

IDENIX PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2013 2013-01-01 – 2013-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation